Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer

References

• Oussama MNK, Atord M. Guidelines for the early detection and screening of breast cancer. World Health Organization (EMRO30) 30, 1–55 (2008).
   Google Scholar
• Waks AG, Winer EP. Breast cancer treatment: a review. JAMA 321(3), 288–300 (2019).
   PubMed Web of Science ®Google Scholar
• Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Epidemiology and risk factors. Lancet 397, 1750–1769 (2021).
   PubMed Web of Science ®Google Scholar
• Harbeck N, Burstein HJ, Hurvitz SA, Johnston S, Vidal GA. A look at current and potential treatment\approaches for hormone receptor-positive, HER2-negative early breast cancer. Cancer 128, 2209–2223 (2022).
   PubMed Web of Science ®Google Scholar
• Tong CW, Wu M, Cho W, To KK. Recent advances in the treatment of breast cancer. Front. Oncol. 8, 381990 (2018).
   Web of Science ®Google Scholar
• McAndrew NP, Finn RS. Clinical review on the management of hormone receptor-positive metastatic breast cancer. JCO Oncol. Pract. 18(5), 319–327 (2022).
   PubMedGoogle Scholar
• Arora S, Narayan P, Osgood CL et al. US FDA drug approvals for breast cancer: a decade in review. Clin. Cancer Res. 28(6), 1072–1086 (2022).
   PubMed Web of Science ®Google Scholar
• An J, Peng C, Xie X, Peng F. New advances in targeted therapy of HER2-negative breast cancer. Front. Oncol. 12, 828438 (2022).
   PubMed Web of Science ®Google Scholar
• Cui W, Aouidate A, Wang S, Yu Q, Li Y, Yuan S. Discovering anti-cancer drugs via computational methods. Front. Pharmacol. 11, 733 (2020).
   PubMed Web of Science ®Google Scholar
• Quijia CR, Chorilli M. Piperine for treating breast cancer: a review of molecular mechanisms, combination with anticancer drugs, and nanosystems. Phytother. Res. 36(1), 147–163 (2022).
   PubMed Web of Science ®Google Scholar
• Veazey K. What to know about anthracycline chemotherapy Medical News Today (2022). www.medicalnewstoday.com/articles/anthracycline-chemotherapy#how-effective-is-it
   Google Scholar
• Breastcancer.org. Anthracycline chemo regimen seems better than regimen without anthracycline for early-stage, HER2-negative, high-risk disease (2016). www.breastcancer.org/research-news/chemo-w-anthracycline-better-for-some
   Google Scholar
• Anthracyclines side effects and late effects (no date). www.idc-online.com/technical_references/pdfs/chemical_engineering/Anthracyclines_Side_Effects_and_Late_Effects.pdf
   Google Scholar
• Venkateah P, Kasi A. Anthracyclines. In: StatPearls. FL, USA (2022). www.ncbi.nlm.nih.gov/books/NBK538187/
   Google Scholar
• Petrou A, Fesatidou M, Geronikaki A. Thiazole ring – a biologically active scaffold. Molecules 26(11), 3166 (2021).
   PubMed Web of Science ®Google Scholar
• Scott KA, Njardarson JT. Analysis of US FDA-approved drugs containing sulfur atoms. Sulfur Chemistry 1(1), 1–34 (2019).
   Google Scholar
• Sharma PC, Bansal KK, Sharma A, Sharma D, Deep A. Thiazole-containing compounds as therapeutic targets for cancer therapy. Eur. J. Med. Chem. 188, 112016 (2020).
   PubMed Web of Science ®Google Scholar
• Pola S. Significance of thiazole-based heterocycles for bioactive systems. In: Scope of Selective Heterocycles from Organic and Pharmaceutical Perspective. Varala R ( Ed.). Janeza Trdine 9, 51000, Riieka, Coratia, 13–62 (2016).
   Google Scholar
• Zheng S, Zhong Q, Xi Y et al. Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion. J. Med. Chem. 57(15), 6653–6667 (2014).
   PubMed Web of Science ®Google Scholar
• Makam P, Thakur PK, Kannan T. In vitro and in silico antimalarial activity of 2-(2-hydrazinyl)thiazole derivatives. Eur. J. Pharm. Sci. 52, 138–145 (2014).
   PubMed Web of Science ®Google Scholar
• Dey S, Das A, Yadav RN et al. Visible light-induced ternary electron donor–acceptor complex enabled synthesis of 2-(2-hydrazinyl) thiazole derivatives and the assessment of their antioxidant and antidiabetic therapeutic potential. Org. Biomol. Chem. 21(8), 1771–1779 (2023).
   PubMed Web of Science ®Google Scholar
• Jadav SS, Kaptein S, Timiri A et al. Design, synthesis, optimization and antiviral activity of a class of hybrid dengue virus E protein inhibitors. Bioorg. Med. Chem. Lett. 25(8), 1747–1752 (2015).
   PubMed Web of Science ®Google Scholar
• Alsharekh MM, Althagafi II, Shaaban MR, Farghaly TA. Microwave-assisted and thermal synthesis of nanosized thiazolyl-phenothiazine derivatives and their biological activities. Res. Chem. Intermed. 45, 127–154 (2019).
   Web of Science ®Google Scholar
• Yurttaş L, Çavuşoğlu BK, Cantürk Z. Novel 2-(2-hydrazinyl) thiazole derivatives as chemotherapeutic agents. Synthetic Communications 50(20), 3072–3079 (2020).
   Web of Science ®Google Scholar
• de Santana TI, de Oliveira BM, de Moraes GPAT et al. Synthesis, anticancer activity and mechanism of action of new thiazole derivatives. Eur. J. Med. Chem. 144, 874–886 (2018).
   PubMed Web of Science ®Google Scholar
• Filimonov AS, Chepanova AA, Luzina OA et al. New hydrazinothiazole derivatives of usnic acid as potent Tdp1 inhibitors. Molecules 24(20), 3711 (2019).
   PubMed Web of Science ®Google Scholar
• Zakharenko AL, Luzina OA, Sokolov DN et al. Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topotecan on in vivo tumor models. Eur. J. Med. Chem. 161, 581–593 (2019).
   PubMed Web of Science ®Google Scholar
• Chimenti F, Bizzarri B, Maccioni E et al. A novel histone acetyltransferase inhibitor modulating Gcn5 network: cyclopentylidene-[4-(4′-chlorophenyl)thiazol-2-yl) hydrazone. J. Med. Chem. 52(2), 530–536 (2009).
   PubMed Web of Science ®Google Scholar
• Zaki I, Abdelhameid MK, El-Deen IM, Wahab AHAA, Ashmawy AM, Mohamed KO. Design, synthesis and screening of 1,2,4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line. Eur. J. Med. Chem. 156, 563–579 (2018).
   PubMed Web of Science ®Google Scholar
• Fantacuzzi M, De Filippis B, Gallorini M et al. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors. Eur. J. Med. Chem. 185, 111815 (2020).
   PubMed Web of Science ®Google Scholar
• Blackburn HL, Ellsworth DL, Shriver CD, Ellsworth RE. Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism and response to endocrine therapy. Cancer Causes Control 26, 319–332 (2015).
   PubMed Web of Science ®Google Scholar
• Long JR, Kataoka N, Shu XO et al. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival. Cancer Epidemiol. Biomarkers Prev. 15(11), 2115–2122 (2006).
   PubMed Web of Science ®Google Scholar
• Butti R, Das S, Gunasekaran VP, Yadav AS, Kumar D, Kundu GC. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Mol. Cancer 17(1), 1–18 (2018).
   PubMedGoogle Scholar
• Ghosh D, Egbuta C, Lo J. Testosterone complex and non-steroidal ligands of human aromatase. J. Steroid Biochem. Mol. Biol. 181, 11–19 (2018).
   PubMed Web of Science ®Google Scholar
• Tong L, Warren TC, King J, Betageri R, Rose J, Jakes S. Crystal structures of the human p56lckSH2 domain in complex with two short phosphotyrosyl peptides at 1.0 Å and 1.8 Å resolution. J. Mol. Biol. 256(3), 601–610 (1996).
   PubMed Web of Science ®Google Scholar
• Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J. Med. Chem. 49(11), 3315–3321 (2006).
   PubMed Web of Science ®Google Scholar
• Secci D, Carradori S, Bizzarri B et al. Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors. Bioorg. Med. Chem. 22(5), 1680–1689 (2014).
   PubMed Web of Science ®Google Scholar
• Kaminskyy D, Kryshchyshyn A, Lesyk R. 5-Ene-4-thiazolidinones – an efficient tool in medicinal chemistry. Eur. J. Med. Chem. 140, 542–594 (2017).
   PubMed Web of Science ®Google Scholar
• Kheirollahi A, Pordeli M, Safavi M, Mashkouri S, Naimi-Jamal MR, Ardestani SK. Cytotoxic and apoptotic effects of synthetic benzochromene derivatives on human cancer cell lines. Naunyn Schmiedebergs Arch. Pharmacol. 387, 1199–1208 (2014).
   PubMed Web of Science ®Google Scholar
• Mohammed FZ, Rizzk YW, El Deen IM et al. Design, synthesis, cytotoxic screening and molecular docking studies of novel hybrid thiosemicarbazone derivatives as anticancer agents. Chem. Biodivers. 18(12), e2100580 (2021).
   PubMed Web of Science ®Google Scholar
• Mohammed FZ, Rizzk YW, El-Deen IM et al. Discovery of 2-amino-4H-1,3,4-thiadiazine-5 (6H)-one derivatives and their in vitro antitumor investigation. ChemistrySelect 7(7), e202104333 (2022).
   Web of Science ®Google Scholar
• Wu CS, Chen J, Chen JJW et al. Terpinen-4-01 induces apoptosis in human normal cell lung cancer in vitro and in vivo. Evid. Based Complement. Altern. Med. 2012, 818261 (2012).
   PubMed Web of Science ®Google Scholar